UGC Approved Journal no 63975(19)

ISSN: 2349-5162 | ESTD Year : 2014
Call for Paper
Volume 11 | Issue 10 | October 2024

JETIREXPLORE- Search Thousands of research papers



WhatsApp Contact
Click Here

Published in:

Volume 10 Issue 8
August-2023
eISSN: 2349-5162

UGC and ISSN approved 7.95 impact factor UGC Approved Journal no 63975

7.95 impact factor calculated by Google scholar

Unique Identifier

Published Paper ID:
JETIR2308395


Registration ID:
523500

Page Number

d764-d777

Share This Article


Jetir RMS

Title

Stability Indicating RP-HPLC Method Development and Validation: Strategy to Minimize Run Time and Retention Time Using Telmisartan in Combination and Single Dosage form and Determine its Stability

Abstract

: A simple, specific, linear, precise and accurate reverse phase liquid chromatographic method was developed to minimize run time and retention time of Telmisartan and Hydrochlorothiazide in combination and single dosage forms. The chromatographic separation was performed using Prudent C 8 Column (60 x 3 mm, 5 μm particle size). Mobile phase used was Gradient composed of buffer and Solution A was selected and a flow rate of 1.3 ml/minute was monitored with injection volume of 5 μl. Detection was carried out at 270 nm for Hydrochlorothiazide (HCTZ) and 298 nm for Telmisartan (TMS). The method was validated as per ICH guidelines. The retention time for TMS was observed as 3.6min and for HCTZ was observed as 1.2 min. Linearity range was observed in concentration of 50 - 150 μg/ml. The percentage recovery of TMS was 99% and for HCTZ was 102.6%. The proposed method was validated and successfully applied to the estimation of Telmisartan and Hydrochlorothiazide in tablet dosage forms.

Key Words

Telmisartan, Hydrochlorothiazide, method development, Validation, Force Degradation

Cite This Article

"Stability Indicating RP-HPLC Method Development and Validation: Strategy to Minimize Run Time and Retention Time Using Telmisartan in Combination and Single Dosage form and Determine its Stability", International Journal of Emerging Technologies and Innovative Research (www.jetir.org), ISSN:2349-5162, Vol.10, Issue 8, page no.d764-d777, August-2023, Available :http://www.jetir.org/papers/JETIR2308395.pdf

ISSN


2349-5162 | Impact Factor 7.95 Calculate by Google Scholar

An International Scholarly Open Access Journal, Peer-Reviewed, Refereed Journal Impact Factor 7.95 Calculate by Google Scholar and Semantic Scholar | AI-Powered Research Tool, Multidisciplinary, Monthly, Multilanguage Journal Indexing in All Major Database & Metadata, Citation Generator

Cite This Article

"Stability Indicating RP-HPLC Method Development and Validation: Strategy to Minimize Run Time and Retention Time Using Telmisartan in Combination and Single Dosage form and Determine its Stability", International Journal of Emerging Technologies and Innovative Research (www.jetir.org | UGC and issn Approved), ISSN:2349-5162, Vol.10, Issue 8, page no. ppd764-d777, August-2023, Available at : http://www.jetir.org/papers/JETIR2308395.pdf

Publication Details

Published Paper ID: JETIR2308395
Registration ID: 523500
Published In: Volume 10 | Issue 8 | Year August-2023
DOI (Digital Object Identifier):
Page No: d764-d777
Country: Thane, Maharashtra, India .
Area: Chemistry
ISSN Number: 2349-5162
Publisher: IJ Publication


Preview This Article


Downlaod

Click here for Article Preview

Download PDF

Downloads

00094

Print This Page

Current Call For Paper

Jetir RMS